Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Protein Design up on VEGF, IBD news

PDLI was up $2.15 (18%) to $13.80 on 11.7 million shares on Monday, after announcing progress with its internal inflammatory

Read the full 205 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE